Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus

Published:2020-10-13 Issue:2 Volume:4 Page:2000203
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Adv. Therap.

Author:

Majumder Joydeb¹^ORCID,Minko Tamara¹^ORCID

Affiliation:

1. Department of Pharmaceutics Ernest Mario School of Pharmacy, Rutgers The State University of New Jersey Piscataway NJ 08854 USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry, medical,Genetics(clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.202000203

Reference223 articles.

1. World Health Organisation https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death(accessed: July2020).

2. Docetaxel (Taxotere): Single agent activity, development of combination treatment and reducing side-effects

3. The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems

4. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in the therapeutic potential of nanomedicines for pulmonary disorders;Emergent Materials;2024-04-24

2. Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer;Cancers;2024-04-20

3. Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer;Small;2024-02-11

4. Advanced Nanomaterials, Medical Materials, and Nanotechnology for the Improved Patient Care;New Technologies for Energy Transition Based on Sustainable Development Goals;2024

5. Dissecting the in vitro fate of plant-derived bioactive encapsulated nanoparticles in lung diseases;Food Bioscience;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3